Accumulated α-synuclein affects the progression of GM2 gangliosidoses

• The accumulation of α-synuclein are caused defective autophagy and ubiquitin proteasome pathways in the neuron of Hexb −/− mice.
• Dysfunction of autophagy and ubiquitin proteasome pathways are caused the dysfunction of mitochondria in the neuron of Hexb −/− mice.
• Hexb −/− ASyn −/− mice showed impaired cellular damage by oxidative stress in the neuron of Hexb −/− mice.
• Hexb −/− ASyn −/− mice demonstrated active microglia levels and less dopaminergic neuron loss.
• The accumulation of α-synuclein is a slight impact on the clinical condition in Hexb −/− mice.

The accumulation of α-synuclein (ASyn) has been observed in several lysosomal storage diseases (LSDs) but it remains unclear if ASyn accumulation contributes to LSD pathology. ASyn also accumulates in the neurons of Sandhoff disease (SD) patients and SD model mice (Hexb −/− ASyn +/+ mice). SD is a lysosomal storage disorder caused by the absence of a functional β-subunit on the β-hexosaminidase A and B enzymes, which leads to the accumulation of ganglioside in the central nervous system. Here, we explored the role of accumulated ASyn in the progression of Hexb −/− mice by creating a Hexb −/− ASyn −/− double-knockout mice. Our results show that Hexb −/− ASyn −/− mice demonstrated active microglia levels and less dopaminergic neuron loss, without altering the neuronal storage of ganglioside. The autophagy and ubiquitin proteasome pathways are defective in the neurons of Hexb −/− ASyn +/+ mice. In ultrastructural physiological studies, the mitochondria structures look degenerated and dysfunctional. As a result, expression of manganese superoxide dismutase 2 are reduced, and reactive oxygen species-mediated oxidative damage in the neurons of Hexb −/− ASyn +/+ mice. Interestingly, these dysfunctions improved in Hexb −/− ASyn −/− mice. But any clinical improvement were hardly observed in Hexb −/− ASyn −/− mice.Taken together, these findings suggest that ASyn accumulation plays an important role in the pathogenesis of neuropathy in SD and other LSDs, and is therefore a target for novel therapies.